Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.

Researchers developed a method to measure drugs in hair follicles and found that both water-loving and fat-loving drugs can be detected after being applied to the skin.

Far-infrared radiation improves stem cell growth and movement, helping heart therapy.

Radiofrequency treatment helps rejuvenate skin by boosting collagen and blood vessel growth.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

PRAME helps distinguish between benign and malignant skin cells in most cases.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Patients with alopecia areata on ritlecitinib responded well to tetanus and meningococcal vaccines.

Topical radioprotectors can reduce radiation-induced hair loss.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Retinoic acid-binding proteins in skin are regulated by β-catenin and Notch signalling.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Rhodamin B stain is inconsistent for keratin in skin samples.

Precise objectives can improve student achievement in health education.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

OR2AT4 helps reduce aging and cell damage in human skin cells.